openPR Logo
Press release

Macular Degeneration Treatment Market: Rising CAGR of 12.4% and Exciting Future Trends

01-30-2025 07:00 AM CET | Food & Beverage

Press release from: The Business Research Company

Macular Degeneration Treatment Market

Macular Degeneration Treatment Market

This report highlights the astonishing growth trajectory of the macular degeneration treatment market, which is expected to reach $12.42 billion in 2025, marking a compound annual growth rate (CAGR) of 12.4%.

What Is The Projected Market Size Of The Global Macular Degeneration Treatment Market And Its Growth Rate?
The market size and growth rate for the global macular degeneration treatment market are:
• The market grew from $11.05 billion in 2024 to $12.42 billion in 2025, marking a CAGR of 12.4%.
• The growth during this period can be attributed to lifestyle changes, aging population, and healthcare infrastructure development.
• Rapid growth is anticipated in the coming years, with the market predicted to reach $19.06 billion in 2029 at a CAGR of 11.3%.
• Factors contributing to this forecasted growth include advancements in research, increased healthcare expenditure, rising incidence rates, and global efforts for vision health.

What Is Driving The Growth In The Macular Degeneration Treatment Market?

The increasing burden of retinal disorders is expected to propel the growth of the macular degeneration treatment market. These disorders affect the way individuals process visual information, leading to distorted or absent vision. For instance, the American Academy of Ophthalmology predicts that in 2050, an estimated 7.32 million people in the United States will suffer from primary open-angle glaucoma. As a result, the increasing burden of retinal disorders is driving the growth of the macular degeneration treatment market.

Request A Free Sample Copy:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5799&type=smp

Who Are the Key Players Driving Macular Degeneration Treatment Market Growth?

Key companies operating in the macular degeneration treatment market include:

• Pfizer Inc.
• F. Hoffmann-La Roche Ltd.
• Allergan Inc.
• Bayer AG
• Novartis AG
• GlaxoSmithKline plc
• Panoptica
• Regeneron Pharmaceuticals Inc.
• Bausch Health Companies Inc.
• Santen Pharmaceuticals

What Are The Key Trends In The Macular Degeneration Treatment Market?

Notable trends in the macular degeneration treatment market include:

• Focus on neuroprotection and regeneration therapies
• Expansion of telemedicine and remote monitoring
• Personalized medicine approaches
• Investigation of stem cell therapies
• Patient-focused initiatives for awareness and education

What Are The Segments Of The Global Macular Degeneration Treatment Market?

The global macular degeneration treatment market is segmented by:

• Stage of Disease: Early-Stage AMD, Intermediate AMD, Late-Stage AMD
• End User: Ambulatory Surgical Centers, Ophthalmic Clinics, Hospitals
• Route of Administration: Oral, Injectable, Other Route of Administration
• Types: Wet Macular Degeneration, Dry Macular Degeneration

Which Region Leads The Macular Degeneration Treatment Market?

North America was the largest region in the macular degeneration treatment market in 2024. Meanwhile, Asia-Pacific is expected to be the fastest-growing region in the forecast period. The macular degeneration treatment market report covers the following regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Pre-book the report for swift delivery:
https://www.thebusinessresearchcompany.com/report/macular-degeneration-treatment-global-market-report

What Is Covered In The Macular Degeneration Treatment Market Global Market Report?
- Market Size Analysis: Analyze the Macular Degeneration Treatment Market size by key regions, countries, product types, and applications.

- Market Segmentation Analysis: Identify various subsegments within the Macular Degeneration Treatment Market for effective categorization.

- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.

- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.

- Market Contribution: Evaluate contributions of different segments to the overall Macular Degeneration Treatment Market growth.

- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.

- Industry Challenges: Analyze challenges and risks affecting the Macular Degeneration Treatment Market.

- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Request Customization for This Report:
https://www.thebusinessresearchcompany.com/customise?id=5799&type=smp

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Macular Degeneration Treatment Market: Rising CAGR of 12.4% and Exciting Future Trends here

News-ID: 3840953 • Views:

More Releases from The Business Research Company

Segment Evaluation and Major Growth Areas in the Personalized Testing and Supplements Market
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future. Market Valuation and Expansion Forecast for Personalized Testing
Top Players and Market Competition in the Skin Microbiome Industry
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry. Projected Expansion in the Skin
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market Landscape
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory. Steady Growth Expected in Upadacitinib Market Size Through 2029 The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Market
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field. Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics

All 5 Releases


More Releases for Macular

Elevated Diabetes Prevalence Fuels Growth In The Macular Edema And Macular Degen …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Macular Edema and Macular Degeneration Market Size By 2025? The market encompassing macular edema and macular degeneration has experienced substantial expansion recently, projected to increase from a value of $9.65 billion in 2024 to $10.33 billion in 2025, reflecting a compound annual growth rate (CAGR)
2025-2034 Macular Edema and Macular Degeneration Market Roadmap: Insights for Co …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts How Large Will the Macular Edema and Macular Degeneration Market Size By 2025? In the past few years, the market size for macular edema and macular degeneration has seen significant growth. It is projected to increase from $9.65 billion in 2024 to $10.43 billion in 2025, exhibiting a compound
Macular Edema and Macular Degeneration Market Outlook 2025-2034: Key Trends, Gro …
"How Big Is the Macular Edema and Macular Degeneration Market Expected to Be, and What Will Its Growth Rate Be? The macular edema and macular degeneration market has seen significant growth in recent years. It will expand from $9.65 billion in 2024 to $10.43 billion in 2025, with a CAGR of 8.1%. Factors contributing to this growth include the aging population, increasing diabetes prevalence, early diagnosis and awareness, global initiatives in
Macular Edema and Macular Degeneration Market to Reach $22.51 Billion by 2034
The global macular edema and macular degeneration market, valued at $10.33 billion in 2023, is on track to grow at a remarkable compound annual growth rate (CAGR) of 7.34%, reaching $22.51 billion by 2034. This substantial market expansion is being fueled by rising treatment innovations, an increasing global prevalence of related diseases, and a surge in technological advancements in diagnostics and therapies. Download White Paper: https://www.towardshealthcare.com/download-statistics/5375 Market Overview and Key Drivers The macular
Macular Edema and Macular Degeneration Market Size, Trends, Growth, Outlook 2024 …
"The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033. Macular Edema and Macular Degeneration Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance. The Market Size Is Expected To Reach $12.84
Macular Edema and Macular Degeneration Market: Key Trends, Competitor Analysis, …
"Exploring the Global Macular Edema and Macular Degeneration Market: A Comprehensive Overview Insights into Macular Edema and Macular Degeneration Market: Global Trends and Analysis Macular Edema and Macular Degeneration Industry - Key Market Dynamics and Trends The macular edema and macular degeneration market size has grown strongly in recent years. It will grow from $8.84 billion in 2023 to $9.65 billion in 2024 at a compound annual growth rate (CAGR) of 9.1%. The